Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Esperion Theraptc
(NQ:
ESPR
)
25.93
USD
+0.48 (+1.89%)
Official Closing Price
Updated: 7:39 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Esperion Theraptc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
NASDAQ:ESPR Shareholder Notice: Lawsuit Alleges Misleading Statements by Esperion Therapeutics, Inc
May 22, 2018
San Diego, CA -- (SBWIRE) -- 05/22/2018 -- An investor, who purchased shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR), filed a lawsuit over alleged violations of Federal Securities Laws by...
From
SBWire - Latest Press Releases
Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.
May 22, 2018
The law firm of Kessler Topaz Meltzer & Check, LLP announces that an investor class action lawsuit has been filed against Esperion Therapeutics, Inc. (Nasdaq: ESPR) (“Esperion”) on behalf of purchasers...
From
Business Wire News Releases
Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference
May 22, 2018
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
May 19, 2018
From
ACCESSWIRE
ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
May 18, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased...
From
GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018
May 17, 2018
Levi & Korsinsky notifies Esperion shareholders of commencement of a class action.
From
Business Wire News Releases
ESPR REMINDER: Pawar Law Reminds Investors of Important July 6, 2018 Lead Plaintiff Deadline in Class Action– ESPR
May 17, 2018
From
ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 – ESPR
May 16, 2018
The following statement is being issued by Levi & Korsinsky, LLP:
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
May 16, 2018
From
ACCESSWIRE
ESPR ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important July 6 Deadline in Class Action
May 16, 2018
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February 22, 2017 through May 1, 2018, both dates inclusive...
From
Business Wire News Releases
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Esperion Therapeutics, Inc. (ESPR)
May 15, 2018
The Klein Law Firm reminds investors of the commencement of an investigation of Esperion Therapeutics, Inc.
From
Business Wire News Releases
DEADLINE ALERT: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. – ESPR
May 14, 2018
Kaskela Law LLC alerts Esperion Therapeutics, Inc. (NASDAQ:ESPR) (“Esperion” or the “Company”) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’s...
From
GlobeNewswire News Releases
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Esperion Therapeutics, Inc. (ESPR)
May 14, 2018
The Klein Law Firm announces the commencement of an investigation of Esperion Therapeutics, Inc.
From
Business Wire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm
May 14, 2018
Bragar Eagel & Squire Reminds Investors of Class Action Lawsuit Against Esperion Therapeutics (ESPR) and Encourages Investors to Contact the Firm
From
Business Wire News Releases
INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. -- ESPR
May 14, 2018
From
ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
May 12, 2018
From
ACCESSWIRE
ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
May 11, 2018
The Law Offices of Vincent Wong reminds investors of an investigation concerning Esperion Therapeutics, Inc.
From
Business Wire News Releases
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
May 10, 2018
From
ACCESSWIRE
Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Filed Against Esperion Therapeutics, Inc. - ESPR
May 10, 2018
From
ACCESSWIRE
ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
May 10, 2018
The Law Offices of Vincent Wong notifies investors in Esperion of a class action.
From
Business Wire News Releases
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc.
May 10, 2018
Federman & Sherwood announces that on May 7, 2018, a class action lawsuit was filed in the United States District Court for the District of Michigan against Esperion Therapeutics, Inc. (NASDAQ:ESPR)....
From
GlobeNewswire News Releases
Important Deadline Notice for Esperion Therapeutics, Inc. Shareholders - ESPR
May 10, 2018
From
ACCESSWIRE
Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2018 Healthcare Conference
May 10, 2018
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with...
From
GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
May 09, 2018
Levi & Korsinsky reminds investors it has commenced an investigation of Esperion Therapeutics, Inc.
From
Business Wire News Releases
Deadline Alert for Esperion Therapeutics, Inc. Shareholders in Class Action Lawsuit - ESPR
May 08, 2018
From
ACCESSWIRE
ESPERION INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Esperion Therapeutics, Inc. To Contact The Firm
May 08, 2018
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ:ESPR) of the July 6, 2018 deadline to seek the role...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
May 08, 2018
Levi & Korsinsky announces it has commenced an investigation of Esperion Therapeutics, Inc.
From
Business Wire News Releases
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm
May 08, 2018
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion (ESPR) and Encourages Investors to Contact the Firm
From
Business Wire News Releases
EQUITY ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. – ESPR
May 08, 2018
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February...
From
Business Wire News Releases
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
May 08, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Esperion Therapeutics, Inc. ("Esperion" or the "Company") (NASDAQ: ESPR)...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.